Stemirna Stock

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Sign up today and learn more about Stemirna Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Stemirna Stock

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Funding History

August 2019$100M
June 2021$1.2B

Management

Chief Executive Officer, President & Founder

Hangwen Li

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo